Bonaire, Sint Eustatius and Saba vs Grenada: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bonaire, Sint Eustatius and Saba
0.2%
in 2024
Grenada
0.2%
in 2024
Bonaire, Sint Eustatius and Saba rank
78th
Grenada rank
78th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bonaire, Sint Eustatius and Saba
- Grenada
How they compare
Bonaire, Sint Eustatius and Saba currently reports 0.2% against 0.2% in Grenada, a difference of 0.0%.
Across all 10 years both countries report, Grenada has been ahead every year.
Bonaire, Sint Eustatius and Saba ranks 78th and Grenada ranks 78th of 215 countries.
Head to head by decade
| Decade | Bonaire, Sint Eustatius and Saba | Grenada | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bonaire, Sint Eustatius and Saba or Grenada?
- Bonaire, Sint Eustatius and Saba, at 0.2% against 0.2% in Grenada as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bonaire, Sint Eustatius and Saba and Grenada?
- 0.0%, with Bonaire, Sint Eustatius and Saba ahead.
- How many years of comparable data are there for Bonaire, Sint Eustatius and Saba and Grenada?
- 10 years are reported by both, from 2015 to 2024.
- How do Bonaire, Sint Eustatius and Saba and Grenada rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bonaire, Sint Eustatius and Saba ranks 78th and Grenada ranks 78th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.